|
||||||||||||||||
|
||||||||||||||||
| HUM-MOLGEN -> Events | Search | Write an announcement | ||||||||||||||||
Meetings and Conferences by date |
||||||||||||||||
| November, 10 2026 |
your calendar for events in
genetics, biotechnology and medicine |
|||||||||||||||
| November 2026 | 2026-11-09 Cancer Research: As oncology research continues to advance, understanding the clinical significance of emerging evidence is essential for informing treatment strategies and guiding future research. The European Societ ESMO 2026: Key Findings for Cancer Care and Drug Development |
Xtalks — The Life Science Community™, Online webinar | ||||||||||||||
| 2026-11-09 Others: Liquid biopsy has made it possible to detect and characterize cancer from a blood sample, with much of the field focused on circulating tumor DNA (ctDNA). Detection in early-stage disease remains chal Beyond ctDNA: EVPs and the Future of Early Cancer Detection |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-11-09 Microbiology / Virology: The diabetes clinical trial landscape is evolving rapidly. As type 1 diabetes programs expand and innovative therapies, including cell and gene therapies, move into clinical development, sponsors face Advancing Diabetes Clinical Trials Through Integrated Technology and Operational Oversight |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-11-10 Microbiology / Virology: For neurodegenerative disease clinical trials, understanding how a condition is progressing and whether a treatment is having an effect can be difficult using traditional assessments alone. Biomarker From Detection to Decisions: Biomarkers in Neurodegenerative Disease |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-11-10 Others: Early-phase neuroscience trials have traditionally focused primarily on establishing safety and tolerability. From Alzheimer's disease to psychiatry, early development strategies can also generate mea Lessons Learned in Neuroscience Drug Development: How Biomarker-based, Evidence-driven Decisions Enable Successful Outcomes |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-11-11 Others: As the biologics landscape becomes increasingly complex and therapeutic modalities grow more sophisticated, potency assay strategies are evolving from regulatory requirements into powerful tools that Potency Assays for Modern Biologics: Expert Insights and Future Trends |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-11-11 Others: Validation programs often experience delays not because of technical challenges, but because documentation gaps can create uncertainty, rework and misalignment across teams. Effective documentation pr Accelerate CQV & Compliance: Why Documentation Quality Drives Operational Readiness |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-11-12 Microbiology / Virology: Cell and gene therapies (CGTs) present unique development challenges, from novel manufacturing processes and delivery methods to complex nonclinical programs and evolving regulatory expectations. For FDA Meetings: Engaging Regulators Throughout Cell and Gene Therapy Development |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-11-12 Others: Psychiatric drug development still leans on rating scales developed decades ago: subjective instruments that capture how a patient describes feeling but not what the brain is doing. In major depressiv Can Objective Brain Measures Improve MDD Trial Decisions? |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-11-12 Others: Enzyme replacement therapies have transformed the treatment landscape for many rare genetic and metabolic disorders by addressing enzyme deficiencies that drive disease progression. By supplying a fun Enzyme Therapy Manufacturing: Preserving Activity Through Production |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-11-16 Microbiology / Virology: Executing clinical trials in complex glomerular diseases require moving beyond traditional functional involvement. As treatment paradigms and regulatory expectations for surrogate endpoints evolve, in Navigating the Evolving Landscape of Glomerular Disease Clinical Trials |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-11-17 Others: As biopharmaceutical programs advance under increasingly compressed timelines, upstream development teams face pressure to deliver optimized, quality-targeted processes earlier. Early decisions still Accelerate Upstream Process Development Using Hybrid Modeling |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-11-17 Microbiology / Virology: Therapeutic antibodies are a rapidly growing class of drugs. Their application areas are not only limited to the standard immunoglobulin G (IgG) format but can also be extended to novel formats, inclu Platform Selection and Development Strategies for High-Performance Anti-Idiotype Antibody Development – in Just 9 Weeks |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-11-17 Others: Early-phase clinical trials operate under compressed timelines, complex protocols, narrow eligibility criteria and limited patient populations, making even small delays disproportionately costly. For Accelerate Biotech Patient Recruitment with Smarter Site Selection |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-11-18 Others: Successful biologics programs depend on making the right decisions at the right stage of development. Early choices in cell culture strategy, media and feed optimization, downstream recovery, analytic Reduce Biologics Development Risk Across the Product Life Cycle |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-11-18 Others: When it comes to advanced therapies, expanding globally involves more than establishing additional sites or capabilities. Transitioning to multisite clinical trials or preparing for commercialization Scale Advanced Therapy Supply Chains Globally Without Building Globally |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-11-19 Microbiology / Virology: Early-stage oncology development is increasingly global. For emerging biopharma, the goal is not simply to expand into more countries, but to build a development strategy that identifies the right mar Accelerating Early-Stage Oncology Global Drug Development: Connecting West to East |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-11-19 Others: Artificial Intelligence (AI) is rapidly transforming biometrics functions across the clinical trial lifecycle, from protocol design and statistical analysis planning to programming, data standardizati AI Governance in Clinical Trial Biometrics: A Practical Framework for Small-Mid Size Organization |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-11-23 Others: Life sciences small and medium-sized enterprises (SMEs) need to make high-stakes R&D decisions quickly, from understanding disease biology and validating biomarkers to identifying meaningful patient p Population Health Data: Strengthening Decisions for Life Sciences SMEs |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-11-24 Others: Reliable capsid titer measurement is one of the most critical analytical requirements in AAV gene therapy development. However, moving a titer assay from development to a GMP-regulated quality control Reduce AAV Gene Therapy GMP Risks With Regulatory-Ready Titer Assays |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-11-26 Others: Lyophilization has become an important development and commercialization strategy for modern parenteral products, including biologics, antibody-drug conjugates, mRNA-lipid nanoparticles, viral vectors Lyophilization by Design: Improve Stability and Accelerate Scale-Up (Broadcast 2) |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| December 2026 | 2026-12-01 Others: GxP internal audits often require quality teams across the life sciences industry to balance the depth of their assessments with the need for comprehensive coverage. Traditional approaches may involve Improve GxP Audit Coverage and Reduce Compliance Risks |
Xtalks — The Life Science Community™, Online webinar | ||||||||||||||
| 2026-12-01 Neurology / Neuroscience: Neuroscience clinical development is evolving across Alzheimer’s disease, Parkinson’s disease, psychiatry and other complex CNS disorders. Disease heterogeneity, trial accessibility, endpoint selectio Neuroscience Development: Are We Measuring What Matters? |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-12-02 Others: Applied AI and electronic health records (EHR) can strengthen patient recruitment by improving patient identification and providing clinical trial sites with a consolidated view of candidate eligibili Reduce Patient Recruitment Delays With EHR and Applied AI |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-12-02 Microbiology / Virology: Thrombolysis and thrombectomy have transformed acute ischemic stroke care, yet the need for therapies that improve recovery and reduce disability remains. For small and mid-sized biotech companies dev Beyond Thrombolysis and Thrombectomy: Designing and Conducting Successful Stroke Clinical Trials |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-12-02 Cell and Molecular Biology / Anatomy: Super-resolution imaging can reveal biological detail that conventional confocal microscopy cannot resolve, but many workflows still force researchers to choose between resolution, speed, multicolor c Improve Data Quality With Multicolor Super-Resolution Imaging |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-12-03 Pharmacogenetics / Pharmacogenomics: Understanding who the right patients are and how to find them remains a challenge across the therapy lifecycle. From clinical development and trial enrollment through post-approval, each stage generat Use Patient Population Data to Improve Therapy Lifecycle Decisions |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-12-03 Others: Central nervous system (CNS) research presents unique challenges, requiring the capture of multiple types and formats of data from clinicians, patients, caregivers and performance-based assessments. T Strengthen CNS Trial Outcomes Through Smarter Data Capture |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-12-04 Microbiology / Virology: Cell and gene therapy programs bring together scientific innovation and clinical complexity unlike many traditional drug development programs. From selecting meaningful biomarkers and designing fit-fo De-Risking Cell & Gene Therapy Development With Integrated MRL Expertise |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-12-04 Others: Serialization has helped pharmaceutical packaging lines meet compliance requirements, but it has also introduced operational challenges for many manufacturers and CMOs. Codes that fail to meet grading Improve Pharmaceutical Packaging Throughput With Serialization |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-12-07 Microbiology / Virology: Next-generation immunotherapies create interconnected CMC, nonclinical, clinical and regulatory challenges. If key decisions around potency, comparability, model relevance, biomarkers and first-in-hum De-Risking Immunotherapy Development: 5 Key Early Decisions |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-12-07 Others: There is growing pressure for therapeutics to demonstrate meaningful health benefits beyond the traditional weight loss efficacy metrics. For example, body composition assessments are increasingly use Underneath the Lost Kilos: Adipose, Adiposity and Adiposopathy |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-12-08 Others: As Alzheimer's disease (AD) clinical trials are conducted earlier in the disease continuum, efficient approaches to identify appropriate participants are increasingly important. While biomarkers remai Digital Cognitive Assessments for Early Alzheimer’s Clinical Trials |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-12-09 Others: An efficient transition from drug discovery to first-in-human studies requires highly productive clones with the right product quality, scalable processes and rapid process development toward robust G Optimize Cell Line Development Through Quality-Driven Clone Selection |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-12-09 Microbiology / Virology: Cardiovascular trials are becoming harder to execute. Patient populations increasingly overlap across competing studies and sponsors who rely on the same historically top-performing sites face diminis Closing the Cardiovascular Site Gap: Intelligence Meets Site Expansion |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-12-09 Others: Predicting whether a therapeutic protein can be manufactured and formulated successfully typically requires a dedicated experimental campaign for each molecular format. However, the ability to apply e Improve Antibody Development With IgG-Trained Predictive Models |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-12-10 Microbiology / Virology: Inflammatory skin diseases such as psoriasis, hidradenitis suppurativa and atopic dermatitis extend beyond the skin, with growing evidence linking these conditions to obesity, metabolic dysfunction, s Improve Inflammatory Skin Disease Trials Beyond Immune Targets |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-12-10 Others: As nucleic acid therapeutics advance, researchers increasingly need tools that provide more than confirmation of target engagement or tissue exposure. Understanding the localization and distribution o Advances in Nucleic Acid Therapeutics Detection and Biological Imaging (Broadcast 2) |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-12-10 Others: As nucleic acid therapeutics advance, researchers increasingly need tools that provide more than confirmation of target engagement or tissue exposure. Understanding the localization and distribution o Advances in Nucleic Acid Therapeutics Detection and Biological Imaging (Broadcast 1) |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-12-11 Others: Targeted alpha therapies are emerging as a promising area of radiopharmaceutical development, delivering high-potency, short-range radiation designed to target cancer cells while limiting damage to su Overcome Targeted Alpha Therapy Challenges for Clinical Translation |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-12-11 Others: Regulators increasingly want to see the patient voice included to inform drug development and qualitative in-trial patient interviews provide valuable insights into patient experiences that can suppor Improve Pharmacovigilance Compliance in In-Trial Patient Interviews |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-12-11 Others: Despite rapid advances in precision medicine and biomarkers, translating scientific progress into effective oncology research remains challenging. Access to molecular testing, study eligibility, resea Turn Patient Insights into Stronger Oncology Research Strategies |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-12-14 Microbiology / Virology: This webinar is the second in a four-part series from Bioculture and EARA examining the science, regulation and responsibility behind the use of non-human primates (NHPs) in biomedical research. The s Strengthen Preclinical Evidence for New Therapies Using NHP Research |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-12-14 Others: The shift towards home healthcare is transforming the medical device industry. Driven by ageing populations, the growth of remote patient monitoring and increasing demand for patient-centred care, mor Accelerate Medical Device Market Access With Home-Use Compliance |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-12-14 Microbiology / Virology: Psychedelic therapies are rapidly emerging as one of the most promising areas of innovation in central nervous system (CNS) research, offering potential new treatment approaches for individuals living Overcome Barriers to Psychedelic Therapies for CNS Diseases |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-12-15 Others: Decisions made early in the drug development process from preclinical through Phase IIa can disproportionately impact later development as costs increase with each phase. Timely information quantifyin Use PET and MRI Imaging Methods Early to Reduce Drug Development Risk |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-12-16 Others: Spatial biology provides a window into not only what is happening within tissue, but where it is happening. By visualizing and quantifying biomarker expression within intact tissue, researchers can ex Explore Spatial Biology, Experimental Design and Spatial Proteomics |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-12-16 Microbiology / Virology: Therapeutic innovation is moving beyond conventional small molecules and monoclonal antibodies toward complex modalities that can engage previously inaccessible biology, overcome resistance and improv Emerging Therapeutic Modalities and Bioanalytical Strategies |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| 2026-12-17 Microbiology / Virology: In the rapidly evolving landscape of respiratory clinical development, aligning cutting-edge strategies with robust trial design is crucial. Respiratory clinical trials require reliable endpoints that Navigating Respiratory Clinical Trials: Ensuring Endpoint Integrity with Spirometry, HRCT and Patient-Centered Outcomes |
Xtalks — The Life Science Community™, Online webinar | |||||||||||||||
| January 2027 | 2027-01-12 Microbiology / Virology: Real-world data (RWD) is increasingly used to support clinical development, safety evaluation and regulatory evidence generation. However, converting electronic health records, claims and registry dat Use AI to Accelerate RWD Transformation for Regulatory Submissions |
Xtalks — The Life Science Community™, Online webinar | ||||||||||||||
| July 2027 | Boston, MA Gene Therapy: 4th Global Cell and Gene Therapy Summit 4th Global Cell and Gene Therapy Summit (CGT Summit 2027) |
United Scientific Group, Four Points by Sheraton Wakefield Boston Hotel & Conference Center | ||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||